Piotr Jankowski

42.2k total citations · 1 hit paper
211 papers, 2.4k citations indexed

About

Piotr Jankowski is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Piotr Jankowski has authored 211 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Cardiology and Cardiovascular Medicine, 57 papers in Surgery and 33 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Piotr Jankowski's work include Blood Pressure and Hypertension Studies (36 papers), Lipoproteins and Cardiovascular Health (31 papers) and Cardiac Health and Mental Health (29 papers). Piotr Jankowski is often cited by papers focused on Blood Pressure and Hypertension Studies (36 papers), Lipoproteins and Cardiovascular Health (31 papers) and Cardiac Health and Mental Health (29 papers). Piotr Jankowski collaborates with scholars based in Poland, United States and Belgium. Piotr Jankowski's co-authors include Kalina Kawecka−Jaszcz, Danuta Czarnecka, Michel E. Safar, Andrzej Pająk, Ewelina A. Dziedzic, Marek Dąbrowski, Jakub S. Gąsior, Agnieszka Tuzimek, Jacques Blacher and Maciej Banach and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Piotr Jankowski

185 papers receiving 2.3k citations

Hit Papers

Investigation of the Associations of Novel Inflammatory B... 2022 2026 2023 2024 2022 50 100 150

Peers

Piotr Jankowski
Pankaj Arora United States
Kumudha Ramasubbu United States
Jordana B. Cohen United States
Susan Colilla United States
Mahmoud Al Rifai United States
Thao Huynh Canada
Charles Porter United States
Pankaj Arora United States
Piotr Jankowski
Citations per year, relative to Piotr Jankowski Piotr Jankowski (= 1×) peers Pankaj Arora

Countries citing papers authored by Piotr Jankowski

Since Specialization
Citations

This map shows the geographic impact of Piotr Jankowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Jankowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Jankowski more than expected).

Fields of papers citing papers by Piotr Jankowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Jankowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Jankowski. The network helps show where Piotr Jankowski may publish in the future.

Co-authorship network of co-authors of Piotr Jankowski

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Jankowski. A scholar is included among the top collaborators of Piotr Jankowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Jankowski. Piotr Jankowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banach, Maciej, Stanisław Surma, Agata Bielecka‐Dąbrowa, et al.. (2025). Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025.. Archives of Medical Science. 21(1). 1–15. 2 indexed citations
3.
Jankowski, Piotr, et al.. (2024). The prevalence of hyperlipoproteinemia(a) in outpatient cardiology clinic patients of European ancestry: results from a STAR-Lp(a) cross-sectional study. Polskie Archiwum Medycyny Wewnętrznej. 134(11). 4 indexed citations
4.
Kubica, Aldona, Łukasz Pietrzykowski, Piotr Michalski, et al.. (2024). Lipoprotein (a) and the Occurrence of Lipid Disorders and Other Cardiovascular Risk Factors in Patients without Diagnosed Cardiovascular Disease. Journal of Clinical Medicine. 13(16). 4649–4649.
5.
Babicki, Mateusz, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.. (2023). Prevalence and assessment of risk factors among Polish adults with post-COVID syndrome: 12-month follow-up study. Polskie Archiwum Medycyny Wewnętrznej. 133(12). 8 indexed citations
6.
Babicki, Mateusz, Żaneta Kałuzińska‐Kołat, Damian Kołat, et al.. (2023). Clinical and electrocardiographic correlates of myocardial dysfunction after COVID‐19 in nonhospitalised patients in long‐term follow‐up. Data from the polish long‐covid cardiovascular study. Journal of Medical Virology. 95(12). e29331–e29331. 4 indexed citations
7.
Wojciechowska, Wiktoria, Marek Klocek, Agnieszka Pac, et al.. (2022). Impact of Arterial Hypertension and Use of Antihypertensive Pharmacotherapy on Mortality in Patients Hospitalized due to COVID-19: The CRACoV-HHS Study. Hypertension. 79(11). 2601–2610. 8 indexed citations
8.
Jankowski, Piotr, Paweł Kozieł, Grzegorz Bilo, et al.. (2022). Trajectories of Blood Pressure in Patients with Established Coronary Artery Disease over 20 years. International Journal of Hypertension. 2022. 1–7. 1 indexed citations
9.
Banach, Maciej, Jarosław Kaźmierczak, Przemysław Mitkowski, et al.. (2022). Which patients at risk of cardiovascular disease might benefit the most from inclisiran? – The expert opinion of the Polish experts. The compromise between EBM and possibilities in healthcare.. Archives of Medical Science. 18(3). 569–576. 12 indexed citations
10.
Lewek, Joanna, et al.. (2021). COVID-19 and cardiovascular complications – the preliminary results of the LATE-COVID study. Archives of Medical Science. 17(3). 818–822. 31 indexed citations
11.
Bacquer, Dirk De, Catriona Jennings, Erkin М Мirrakhimov, et al.. (2021). Potential for optimizing management of obesity in the secondary prevention of coronary heart disease. European Heart Journal - Quality of Care and Clinical Outcomes. 8(5). 568–576. 9 indexed citations
13.
Śliż, Daniel, Dominik Olejniczak, Paweł Kałużny, et al.. (2020). Dyslipidaemia, carbohydrate metabolism disorders and arterial hypertension detected in academic employees during examinations in occupational medicine. Annals of Agricultural and Environmental Medicine. 28(2). 314–318. 2 indexed citations
14.
Polak, Maciej, Jakub Stokwiszewski, Walerian Piotrowski, et al.. (2015). Ocena ryzyka sercowo-naczyniowego przy pomocy funkcji SCORE w odniesieniu do ryzyka określonego na podstawie umieralności z powodu chorób układu krążenia w Polsce. Homo Politicus (Academy of Humanities and Economics in Lodz).
15.
Jankowski, Piotr, Kalina Kawecka−Jaszcz, Jacek Jassem, et al.. (2009). [Why the ban on smoking should be expanded in Poland?].. PubMed. 67(1). 101–5.
16.
Kawecka−Jaszcz, Kalina, et al.. (2007). Rozpowszechnienie nadciśnienia tętniczego w zależności od płci w świetle badań epidemiologicznych w Polsce. Via Medica Journals. 5 indexed citations
17.
Jankowski, Piotr, Grzegorz Bilo, & Kalina Kawecka−Jaszcz. (2007). The pulsatile component of blood pressure – Its role in the pathogenesis of atherosclerosis. Blood Pressure. 16(4). 238–245. 48 indexed citations
18.
Jankowski, Piotr, Kalina Kawecka−Jaszcz, & Danuta Czarnecka. (2007). Ascending aortic blood pressure waveform is related to coronary atherosclerosis in hypertensive as well as in normotensive subjects. Blood Pressure. 16(4). 246–253. 11 indexed citations
19.
Jankowski, Piotr, Kalina Kawecka−Jaszcz, Grzegorz Bilo, & Andrzej Pająk. (2005). Determinants of poor hypertension management in patients with ischaemic heart disease. Blood Pressure. 14(5). 284–292. 23 indexed citations
20.
Kawecka−Jaszcz, Kalina, et al.. (2004). Cracovian program for secondary prevention of ischaemic heart disease.. European Heart Journal Supplements. 6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026